10 G6PD Deficiency Symptoms You Should Not Ignore

G6PD deficiency is a genetic condition that affects how red blood cells handle stress. G6PD stands for glucose-6-phosphate dehydrogenase, an enzyme that helps protect red blood cells from damage. When the body does not have enough of this enzyme, certain foods, infections, medicines, or chemicals can trigger red blood cells to break down faster than normal. This process is called hemolysis.

Many people with G6PD deficiency feel healthy most of the time and may not know they have it. Symptoms often appear only after exposure to a trigger, such as fava beans, some antibiotics, antimalarial medicines, mothballs, or a serious infection. When hemolysis happens, the body may struggle to replace red blood cells quickly enough, leading to signs such as sudden fatigue, pale skin, yellowing of the eyes, dark urine, shortness of breath, dizziness, or a fast heartbeat.

G6PD deficiency is one of the most common enzyme disorders worldwide. It is estimated to affect more than 400 million people globally, and it is more common in parts of Africa, the Mediterranean, the Middle East, and Asia. Because symptoms can range from mild to severe, awareness matters, especially for families with a known history of the condition.

The warning signs can appear quickly and may become serious if hemolysis is intense. Newborns with G6PD deficiency may develop jaundice, while older children and adults may experience sudden anemia after a trigger. Knowing what to watch for can help people seek medical care earlier and avoid repeated episodes. This article explores 10 G6PD deficiency symptoms you should not ignore, why they happen, and when they may need urgent attention.

What is G6PD Deficiency?

G6PD deficiency is an inherited genetic condition characterized by insufficient levels of the enzyme glucose-6-phosphate dehydrogenase (G6PD), which makes red blood cells highly susceptible to damage and premature destruction (hemolysis) when faced with oxidative stress. This X-linked recessive disorder means it predominantly affects males.

While individuals with the deficiency are typically asymptomatic in their daily lives, exposure to specific oxidative triggers can initiate a cascade of events leading to acute hemolytic anemia, a condition where red blood cells are destroyed faster than the body can replace them. The G6PD enzyme’s role is fundamentally protective, and its absence leaves the body’s oxygen-carrying cells vulnerable.

Primary Role of the G6PD Enzyme In Red Blood Cells

The primary role of the G6PD enzyme in red blood cells is to produce a critical molecule called nicotinamide adenine dinucleotide phosphate (NADPH), which serves as the principal defense against damaging oxidative stress. Red blood cells are unique because they lack mitochondria, the typical powerhouses of other cells, and therefore cannot generate energy or protective compounds through standard metabolic pathways

Consequently, they rely almost exclusively on a pathway known as the pentose phosphate pathway (PPP) for protection, and G6PD is the rate-limiting enzyme that initiates this entire process. Without a functioning G6PD enzyme, the PPP cannot operate effectively, and NADPH levels plummet.

Specifically, NADPH is essential for regenerating a key antioxidant called glutathione. Reduced glutathione is a powerful molecule that directly neutralizes harmful reactive oxygen species (ROS), such as free radicals and peroxides, that are constantly generated during normal metabolism and are significantly increased during illness or exposure to certain chemicals. By donating an electron, glutathione renders these ROS harmless, protecting vital cellular components like the cell membrane and hemoglobin from oxidative damage.

Once glutathione has done its job, it becomes oxidized and inactive. NADPH is the cofactor required by the enzyme glutathione reductase to recycle this oxidized glutathione back into its active, reduced state. Therefore, a steady supply of NADPH is paramount for maintaining a continuous defense. In G6PD-deficient individuals, this recycling process is impaired, leaving red blood cells with a severely diminished capacity to handle any increase in oxidative threats.

What Happens During a Hemolytic Crisis In a Person With G6PD Deficiency?

During a hemolytic crisis, an individual with G6PD deficiency is exposed to a trigger that generates a massive surge of oxidative stress, overwhelming the limited protective capacity of their red blood cells and causing them to rupture and be destroyed in large numbers. This process, known as acute hemolysis, is rapid and can lead to a sudden and severe drop in the red blood cell count.

The sequence begins when a trigger, such as a sulfa drug, fava beans, or a severe infection, introduces or causes the body to produce high levels of reactive oxygen species (ROS). In a healthy individual, the G6PD enzyme would ramp up NADPH production to neutralize these threats. However, in a person with G6PD deficiency, the enzyme cannot respond adequately.

More specifically, without sufficient NADPH to regenerate protective glutathione, the ROS are free to attack the red blood cells. They damage the hemoglobin molecules within the cells, causing them to denature and clump together to form what are known as Heinz bodies.

These damaged cells are then targeted for destruction. This destruction occurs through two main mechanisms: intravascular hemolysis, where the cells burst directly within the bloodstream, and extravascular hemolysis, where they are identified as defective and removed by macrophages in the spleen and liver. The rapid breakdown releases large amounts of hemoglobin into the bloodstream (hemoglobinemia).

This free hemoglobin is filtered by the kidneys, causing the urine to turn dark (hemoglobinuria), and is also broken down into bilirubin. The liver becomes overwhelmed by the excess bilirubin, which then accumulates in the blood and tissues, causing jaundice. This entire cascade results in acute hemolytic anemia and its associated symptoms.

10 Key Symptoms of G6PD Deficiency

Yellowing of the skin (Jaundice)

This occurs because hemolysis releases large amounts of hemoglobin, which is broken down into a yellow-orange pigment called bilirubin. A healthy liver can process a normal amount of bilirubin, but during a hemolytic crisis, the sheer volume overwhelms the liver’s capacity. Consequently, bilirubin builds up in the bloodstream and gets deposited in the skin, giving it a characteristic yellow tint.

Yellowing of the whites of the eyes (Icteric sclera)

This is often one of the first and most apparent signs of jaundice. The sclera, the white part of the eye, has a high affinity for bilirubin, making the yellow discoloration particularly noticeable here. Its presence is a strong clinical indicator that bilirubin levels are significantly elevated.

Extreme tiredness or fatigue

This profound sense of exhaustion is a direct symptom of anemia—the state of having too few red blood cells. Red blood cells are responsible for transporting oxygen from the lungs to all other parts of the body. When their numbers plummet during hemolysis, oxygen delivery is severely compromised. Muscles and organs, including the brain, are starved of the oxygen they need to function, leading to overwhelming fatigue and weakness.

Unusually pale skin (Pallor)

Paleness is another hallmark of acute anemia. The rich, red color of healthy blood, which gives skin its rosy undertones, comes from oxygenated hemoglobin in the red blood cells. When the concentration of these cells drops, especially in the small capillaries just beneath the skin’s surface, the skin loses its color and appears pale or washed out. This can be most easily observed in the nail beds, gums, and the inner lining of the lower eyelids.

Shortness of breath (Dyspnea)

When tissues throughout the body signal a desperate need for more oxygen, the brain instructs the respiratory system to increase its rate and depth of breathing. This is an attempt to maximize oxygen intake from the air.

However, because the problem lies with oxygen transport (not intake), the sensation of being air hungry or breathless persists, even during rest. The individual may feel like they cannot get a satisfying breath, a distressing symptom that reflects the body’s underlying oxygen crisis.

Rapid heart rate (Tachycardia)

In response to the low oxygen-carrying capacity of the blood, the cardiovascular system attempts to compensate by increasing cardiac output. The heart begins to beat much faster to circulate the remaining blood more quickly, hoping to deliver what little oxygen is available to the tissues more frequently. This can be felt as palpitations or a racing pulse and is a sign that the heart is under significant strain as it works overtime to meet the body’s metabolic demands.

Dizziness or lightheadedness

The brain is highly sensitive to oxygen levels and is one of the first organs to be affected by poor oxygen supply (hypoxia). When the anemic blood fails to deliver enough oxygen to the brain, individuals may experience dizziness, lightheadedness, or a feeling of being about to faint (presyncope). In severe cases of hemolysis, this can progress to confusion or loss of consciousness (syncope), highlighting the critical nature of the situation.

Dark, tea-colored or red-colored urine

This is one of the most definitive signs of intravascular hemolysis, where red blood cells are bursting directly within the blood vessels. This process releases free hemoglobin into the plasma.

When the level of free hemoglobin exceeds the binding capacity of proteins designed to carry it, the excess is filtered by the kidneys and passed into the urine. This condition, known as hemoglobinuria, gives the urine a distinctively dark, reddish-brown appearance, often compared to tea or cola. It is a tell-tale sign of rapid and severe hemolysis.

Abdominal or back pain

The pain associated with a hemolytic crisis can be sharp and severe, often localized in the abdomen or lower back. While the exact mechanism is not always clear, it is believed to be multifactorial. The pain may stem from the kidneys being overworked as they filter the large amount of hemoglobin and cellular debris from the blood.

Additionally, the spleen, which is heavily involved in clearing damaged cells, can become rapidly enlarged and stretched, causing pain in the upper left quadrant of the abdomen that may radiate to the back.

Enlarged spleen (Splenomegaly)

The spleen acts as the body’s primary filter for blood, identifying and removing old or damaged red blood cells. During a hemolytic crisis, the spleen goes into overdrive, working to clear the enormous number of damaged and dying cells from circulation. This intense workload causes the spleen to swell and become enlarged, a condition known as splenomegaly.

An enlarged spleen may be tender to the touch and can sometimes be felt by a doctor during a physical examination. It is a direct physical manifestation of the body’s intense effort to manage the consequences of widespread hemolysis.

Common Triggers for Hemolysis in G6PD Deficiency

The most common triggers for hemolysis in G6PD deficiency are a select group of external factors that introduce significant oxidative stress to the body, including certain foods (most notably fava beans), a specific list of medications (such as sulfa drugs and some antimalarials), and the physiological stress from bacterial or viral infections. These triggers generate or contain oxidizing agents that G6PD-deficient red blood cells cannot neutralize due to their inability to produce sufficient amounts of the protective enzyme G6PD.

For an individual with this genetic condition, who is otherwise healthy and asymptomatic, exposure to one of these triggers can rapidly induce an episode of acute hemolytic anemia. Therefore, the cornerstone of managing G6PD deficiency is lifelong avoidance of these known triggers.

Specific Foods and Substances to Avoid

The most critical food to avoid for individuals with G6PD deficiency is fava beans, while strong caution is also necessary with exposure to the chemical naphthalene, commonly found in mothballs. While the list of absolute dietary prohibitions is relatively short, its importance cannot be overstated, as exposure can lead to a severe form of hemolysis known as favism. These substances contain powerful oxidizing compounds that directly initiate the destruction of vulnerable red blood cells.

Fava beans is the most infamous and potent dietary trigger. Fava beans (also known as broad beans) contain high concentrations of two compounds, vicine and convicine.

Upon ingestion, these compounds are metabolized in the body to create highly reactive oxygen species, including hydrogen peroxide. This creates an intense oxidative assault that overwhelms the deficient protective mechanisms in the red blood cells of G6PD-deficient individuals, leading to rapid and severe hemolysis. The reaction, termed favism, can be life-threatening and can occur within hours of eating the beans, whether they are fresh, dried, or cooked.

While fava beans are the primary concern, some medical guidelines suggest caution with other legumes, though the risk is considered much lower and less consistent. For most individuals with G6PD deficiency, other beans and peas do not pose a threat. However, due to variations in the severity of the deficiency and individual sensitivity, some people may react to other legumes. It is generally advised to be cautious and discuss dietary specifics with a healthcare provider.

Naphthalene is a chemical, not a food, but it can be ingested or inhaled. It is the active ingredient in traditional mothballs and can also be found in some deodorant blocks and toilet bowl cleaners. Exposure to naphthalene fumes or accidental ingestion is a well-documented trigger for severe hemolysis in G6PD-deficient individuals, particularly in children. It is crucial to use naphthalene-free alternatives for pest control in households where someone with the condition resides.

Infections or Illnesses

Infections and illnesses are among the most common and potent triggers for a hemolytic episode in individuals with G6PD deficiency. The oxidative stress that leads to hemolysis is not always from an external substance; it can be generated internally by the body’s own immune system as it fights off invading pathogens. During an infection, whether bacterial or viral, the body mounts a powerful inflammatory response to eliminate the threat.

Specifically, immune cells such as neutrophils and macrophages are activated to attack and destroy pathogens. A key part of their strategy is a process called the “respiratory burst” or “oxidative burst,” where they produce and release a large quantity of reactive oxygen species (ROS), including superoxide radicals and hydrogen peroxide. These ROS are highly effective at killing bacteria and viruses but also create a state of high oxidative stress throughout the body.

In a person with a normal G6PD enzyme, red blood cells can easily withstand this collateral damage. However, in an individual with G6PD deficiency, their red blood cells lack the necessary NADPH to defend themselves against this onslaught of internally generated ROS.

As a result, the red blood cells are damaged and destroyed, leading to hemolysis. Common infections known to trigger hemolysis include viral hepatitis, pneumonia, typhoid fever, and other severe systemic infections. Therefore, any febrile illness in a person with G6PD deficiency should be monitored closely for signs of hemolysis.

G6PD Deficiency Diagnosis

The confirmation of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency relies on direct measurement of the enzyme’s activity in red blood cells through specific laboratory tests. The most common screening method is the fluorescent spot test, a qualitative assay that detects the production of NADPH (nicotinamide adenine dinucleotide phosphate) from NADP.

In individuals with normal G6PD levels, the blood spot will fluoresce brightly under ultraviolet light because NADPH is fluorescent. In contrast, a sample from a G6PD-deficient individual will show little to no fluorescence, indicating impaired enzyme function.

While rapid and effective for screening, this test does not quantify the degree of deficiency. For a definitive diagnosis and to determine the severity, a quantitative spectrophotometric analysis is performed. This test measures the exact rate at which G6PD converts NADP to NADPH, providing a precise measurement of enzyme activity.

It is critical to consider the timing of these tests for accurate results. Testing should not be performed during or immediately after a hemolytic episode. During such an event, the oldest red blood cells, which have the lowest G6PD levels, are destroyed first.

The body responds by releasing a high number of young red blood cells (reticulocytes) from the bone marrow, which naturally have higher levels of G6PD activity. This can temporarily elevate the overall G6PD level in the blood sample, potentially leading to a false negative result. To avoid this, physicians typically recommend waiting several weeks after a hemolytic crisis has resolved to perform the diagnostic tests, ensuring the red blood cell population has stabilized and reflects the individual’s true baseline enzyme activity.

How is Neonatal Jaundice Related to G6PD Deficiency?

Neonatal jaundice, a yellowing of a newborn’s skin and eyes, is a common and usually harmless condition caused by an accumulation of bilirubin. However, in newborns with G6PD deficiency, it can become severe and dangerous, representing one of the most significant clinical manifestations of the disorder in this age group.

The connection lies in the vulnerability of a newborn’s red blood cells combined with their immature liver function. Newborns naturally have a higher rate of red blood cell turnover and a liver that is not yet fully efficient at processing bilirubin, a yellow pigment produced during the normal breakdown of red blood cells.

In a G6PD-deficient infant, red blood cells are exceptionally fragile and susceptible to oxidative stress, which can be triggered by common perinatal factors like infection, maternal ingestion of certain foods or drugs passed through breast milk, or even the stress of birth itself.

When these triggers cause hemolysis (the rapid destruction of red blood cells), a massive amount of bilirubin is suddenly released into the bloodstream, overwhelming the newborn’s already limited processing capacity. This leads to a rapid and severe rise in bilirubin levels, a condition known as hyperbilirubinemia.

If left untreated, this severe jaundice can lead to acute bilirubin encephalopathy, where excess bilirubin crosses the blood-brain barrier and deposits in brain tissue, causing irreversible neurological damage.

The long-term consequences of this condition, known as kernicterus, include cerebral palsy, hearing loss, and developmental delays. For this reason, many countries with high prevalence rates of G6PD deficiency have implemented newborn screening programs to identify affected infants early, allowing for close monitoring and prompt treatment with phototherapy to prevent these devastating outcomes.

Genetic Inheritance Pattern of G6PD Deficiency

G6PD deficiency is inherited in an X-linked recessive pattern, a genetic characteristic that explains why the condition is far more common and typically more severe in males than in females. The gene responsible for producing the G6PD enzyme is located on the X chromosome, one of the two sex chromosomes. Males have one X and one Y chromosome (XY), while females have two X chromosomes (XX).

Because males have only a single X chromosome, inheriting one copy of the mutated G6PD gene is sufficient for them to express the deficiency. They have no second, normal copy of the gene to compensate for the defective one. Consequently, if a mother is a carrier of the G6PD mutation, there is a 50% chance she will pass the affected X chromosome to each of her sons, who will then have the condition.

For females, the situation is more complex. Since they have two X chromosomes, they must inherit the mutated gene on both chromosomes to have a full expression of G6PD deficiency, which is a rare event. More commonly, a female inherits one mutated X chromosome and one normal X chromosome, making her a heterozygous carrier.

While many female carriers are asymptomatic, they can experience symptoms due to a process called lyonization, or random X-chromosome inactivation. Early in embryonic development, one of the two X chromosomes in each cell is randomly and permanently inactivated.

If, by chance, a significant proportion of a female carrier’s red blood cell precursors inactivate the X chromosome carrying the normal G6PD gene, her overall enzyme activity can be low enough to cause clinical symptoms, particularly when exposed to strong oxidative triggers.

G6PD Deficiency and Other Hemolytic Anemias like Sickle Cell Disease

While both G6PD deficiency and Sickle Cell Disease are inherited conditions that cause hemolytic anemia, they differ fundamentally in their underlying cause, clinical presentation, and pathophysiology. G6PD deficiency is an enzymopathy, meaning it is caused by a deficiency in a critical enzyme (G6PD) needed to protect red blood cells from oxidative damage.

In contrast, Sickle Cell Disease is a hemoglobinopathy, a structural defect in the hemoglobin protein itself, caused by a mutation in the beta-globin gene. This core distinction drives all other differences between the two disorders. The hemolysis in G6PD deficiency is typically episodic and triggered, occurring only when an individual is exposed to a specific oxidative stressor, such as certain drugs, fava beans, or infections. Between these episodes, the individual is usually asymptomatic with a normal blood count.

Conversely, Sickle Cell Disease is characterized by chronic, ongoing hemolysis because the abnormal hemoglobin S (HbS) is inherently unstable. This abnormal hemoglobin causes red blood cells to deform into a rigid, sickle shape, especially under low-oxygen conditions.

These sickled cells are not only fragile and easily destroyed (leading to chronic anemia) but also stiff and sticky, causing them to clump together and block blood flow in small vessels. This blockage, known as a vaso-occlusive crisis, is the hallmark of Sickle Cell Disease and leads to severe pain, tissue ischemia, and progressive organ damage over time, complications not directly associated with G6PD deficiency.

FAQs

1. What foods trigger G6PD?

The most common food trigger for G6PD deficiency is fava beans. In some people, eating fava beans can cause red blood cells to break down quickly, leading to sudden anemia. Some doctors may also advise caution with bitter melon, certain legumes, tonic water, or foods and drinks with strong artificial dyes, but fava beans remain the main food concern. Since triggers can vary, patients should follow the list given by their healthcare provider.

2. Can G6PD go away with age?

No. G6PD deficiency is an inherited condition, so it does not go away as a person gets older. However, symptoms may appear less often if someone learns to avoid triggers such as certain foods, medicines, chemicals, or infections. Many people with G6PD deficiency live normal, active lives with proper awareness and prevention.

3. Can G6PD be passed from father to daughter?

Yes. G6PD deficiency is usually inherited through the X chromosome. A father with G6PD deficiency passes his affected X chromosome to all of his daughters, but not to his sons. Daughters may become carriers or, in some cases, may have symptoms depending on their genetic pattern.

4. Can people with G6PD have kids?

Yes. People with G6PD deficiency can have children. The condition does not usually affect fertility. Still, genetic counseling can help parents understand the chance of passing G6PD deficiency to their children, especially if there is a family history.

5. Is G6PD linked to autism?

There is no strong evidence that G6PD deficiency directly causes autism. Some research has explored possible links, but current evidence does not prove a clear cause-and-effect relationship. Autism is complex and influenced by many genetic and environmental factors.

6. Can G6PD get a tattoo?

Many people with G6PD deficiency can get a tattoo, but they should be careful. The main concerns are infection, unsafe ink, allergic reactions, and poor wound healing. It is best to speak with a doctor first, choose a licensed tattoo studio, and follow aftercare instructions closely.

7. How serious is G6PD deficiency?

G6PD deficiency is often manageable, but it can become serious during a hemolytic episode. Severe fatigue, yellow skin or eyes, dark urine, pale skin, shortness of breath, chest discomfort, dizziness, or rapid heartbeat may signal urgent anemia. In newborns, severe jaundice can also be dangerous if not treated promptly.

Conclusion

G6PD deficiency is a lifelong genetic condition, but many people manage it well once they understand their triggers. The key is prevention. Avoiding fava beans, checking medications before use, staying away from harmful chemicals such as mothballs, and treating infections early can reduce the risk of sudden red blood cell breakdown.

Symptoms such as dark urine, jaundice, unusual weakness, dizziness, fast heartbeat, or breathing difficulty should not be ignored. These signs may mean the body is losing red blood cells faster than it can replace them. With the right care, regular medical guidance, and good awareness, people with G6PD deficiency can protect their health and live safely.

References

• The Hospital for Sick Children – G6PD deficiency
• Cleveland Clinic – G6PD Deficiency
• Healthdirect Australia Limited – G6PD deficiency
• Rady Children’s Health – G6PD Deficiency
• National University Health System – G6PD Deficiency (Children)
• Medline Plus – G6PD Deficiency
• AAFP – Diagnosis and Management of G6PD Deficiency
• The Johns Hopkins University – G6PD (Glucose-6-Phosphate Dehydrogenase) Deficiency
• G6PD Deficiency Foundation – G6PD Deficiency Lifestyle Guide
• The Royal Children’s Hospital – G6PD deficiency
• NORD – Glucose-6-Phosphate Dehydrogenase Deficiency